Opinion
NO. 14-18-00225-CV
04-02-2018
NAVIDEA BIOPHARMACEUTICALS, INC. AND MACROPHAGE THERAPEUTICS, INC., Appellants v. CAPITAL ROYALTY PARTNERS II, L.P., CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A", L.P., CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P., AND CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "B" (CAYMAN) L.P., Appellees
On Appeal from the 151st District Court Harris County, Texas
Trial Court Cause No. 2016-22242
ORDER
Appellants filed a motion requesting review of the trial court's order setting the amount and type of security to suspend enforcement of its judgment. See Tex. R. App. P. 24.4. Having reviewed the motion, we conclude that the trial court did not abuse its discretion in setting the amount and type of security required. See Abdullatif v. Choudhri, 536 S.W.3d 48, 51 (Tex. App.—Houston [14th Dist.] 2017, mand. denied) (reviewing trial court's supersedeas ruling for abuse of discretion). Accordingly, we deny appellants' motion.
PER CURIAM Panel consists of Justices Christopher, Donovan, and Jewell.